Paroxetine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 60505-1317

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 60505-1317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Apo Paxil Cr12 5mg

A pharmaceutical label for Paroxetine HCl Extended-Release Tablets, strength 12.5 mg. The label includes quantity of 30 tablets, NDC 60505-1316-3, and states the product is manufactured by Apotex Corp. Dosage instructions and storage temperature (25°C/77°F) are noted. The label features a barcode and cautions about use of safety closures.*

FDA Label Image

Apo Paxil Cr25mg

Label for Paroxetine HCl Extended-Release Tablets, 25 mg strength, containing 30 tablets. The label shows the NDC 60505-1317-3 and indicates the product is manufactured by Apotex Inc. and Apotex Corp. Usage warnings, storage instructions, and a barcode are also visible on the label.*

FDA Label Image

Apo Paxil Cr37 5mg

Label for Paroxetine HCl Extended-Release Tablets 37.5 mg, containing 30 tablets. The label includes storage instructions, manufacturer Apotex Corp, and a barcode. It states the product is prescription only and provides handling cautions.*

FDA Label Image

Figure1

A pharmacokinetic chart showing fold change and 90% confidence intervals in Cmax and AUC values for various interacting drugs relative to a reference. The drugs listed include Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg, with fold changes plotted on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure2

A forest plot graph depicting fold change and 90% confidence intervals for Cmax and AUC pharmacokinetic parameters of various interacting drugs including Cimetidine 300 mg, Phenobarbital 100 mg, Phenytoin 300 mg, Digoxin 0.25 mg, and Diazepam 5 mg, each administered at different frequencies, relative to a reference value on the x-axis.*

FDA Label Image

Figure3

A scatter plot with horizontal error bars illustrating fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax, AUC, Cmin) relative to reference values. Data are grouped by population characteristics including renal impairment severity, hepatic impairment, age with varying doses, and gender (males). The x-axis is labeled 'Change relative to reference' and ranges from 0.5 to 50.*

FDA Label Image

Gsk Paxil Cr12 5mg

Label for Paroxetine HCl controlled-release tablets, 12.5 mg strength, in a bottle of 30 tablets. Manufactured by GlaxoSmithKline and Apotex Corp. The label includes storage instructions, dispensing warnings, and a barcode. It is marked for prescription use only.*

FDA Label Image

Gsk Paxil Cr25mg

Label for Paroxetine HCl controlled-release tablets, 25 mg strength, containing 30 tablets per container. Manufactured by GlaxoSmithKline and labeled for Apotex Corp. Includes storage instructions and a note on safety closures. The National Drug Code (NDC) is 60505-3674-3.*

FDA Label Image

Gsk Paxil Cr37 5mg

Label for Paroxetine HCl controlled-release tablets, 37.5 mg strength. The label shows this package contains 30 tablets with NDC 60505-3675-3. The labeler is Apotex Corp. Important storage and dispensing instructions are included, along with manufacturer information for GlaxoSmithKline and Apotex Corp. The label indicates prescription-only use.*

FDA Label Image

Structure

Chemical structure of paroxetine hydrochloride, showing its molecular framework including a fluorophenyl group and a methylenedioxyphenyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.